Pharm E2: just the drugs

0.0(0)
studied byStudied by 4 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/34

flashcard set

Earn XP

Description and Tags

not done!

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

35 Terms

1
New cards

Memantine (Namenda XR)

NMDA glutamate receptor antagonist → decreases Glutamate signaling

2
New cards

Donepezil (Aricept)

AChE inhibitors, increase ACh signaling

3
New cards

TCAs

non-specific reuptake blockers, good for resistant depression, but many side effects

  • AMITRIPTYLINE (Elavil), NORTRIPTYLINE (Pamelor)

4
New cards

Tetracyclics (TECAS)

antidepressant by blocking presynaptic autoreceptors

SEs: CV, sedation (blocks histamine)

  • MIRTAZAPINE (Remeron)

5
New cards

SSRIs

  • FLUOXETINE (Prozac), SERTRALINE (Zoloft), CITALOPRAM (Celexa), PAROXETINE (Paxil), ESCITALOPRAM (Lexapro)

  • 5-HT2 is usually the target that we try to stimulate, but we sometimes agonize 5-HT1 (inhibitory) to balance

  • SEs (more manageable than MAOIs and TCAs): 

    • Early onset (transitory): Nausea, anxiety, agitation, insomnia

    • Late onset: weight gain, asthenia (weakness), sexual dysfunction, withdrawal syndrome

  • Combo of drugs may interact and increase 5HT (5HT/serotonin syndrome)

  • SSRIs compete with other drugs for metabolism by CYP enzymes (PK drug-drug interaction)

6
New cards

SNRIs

  • Stronger than SSRIs, for anxiety disorders and chronic nerve pain

  • SEs: dry mouth, insomnia, blurred vision, high BP, seizures from Duloxetine

  • VENLAFAXIN (Effexor XR), DULOXETINE (Cymbalta), DESVENLAFAXINE (Pristiq)

7
New cards

NDRIs

  • Mechanism of Action: like SSRI/SNRI but more potent in inhibiting dopamine reuptake

    • Also nicotinic antagonist → Treats tobacco dependence

  • SEs: lowers seizure threshold (convulsions), insomnia, dry mouth, nausea

  • BUPROPION (Wellbutrin)

8
New cards

5-HT2 receptor modulators

  • simultaneously modulate one+ R and inhibit NT reuptake

  • TRAZODONE (Desyrel)

    • 5-HT2a antagonist

    • 5-HT1a receptor agonist

    • NR and 5-HT reuptake inhibitor

  • SE: dry mouth, nausea/vomiting, fatigue, sedation (tx for insomnia) - all manageable

9
New cards

Phenelzine (Nardil)

irreversible, nonselective MAOI

  • SEs: drowsiness/fatigue, low BP, sleep disturbances, weight gain, blurred vision…

10
New cards

Selegiline (Emsam)

MAO-B Inhibitor (reversible), for Parkinson’s

11
New cards

AMITRIPTYLINE (Elavil)

Tricyclic Antidepressants (TCAs): nonselective reuptake transporter inhibitor

12
New cards

NORTRIPTYLINE (Pamelor)

TCA: nonselective reuptake transporter inhibitors

13
New cards

MIRTAZAPINE (Remeron)

Tetracyclic (TECAS), blocks presynaptic autoreceptors → antidepressant

14
New cards

FLUOXETINE (Prozac)

SSRI

15
New cards

SERTRALINE (Zoloft)

SSRI

16
New cards

CITALOPRAM (Celexa)

SSRI

17
New cards

PAROXETINE (Paxil)

SSRI

18
New cards

ESCITALOPRAM (Lexapro)

SSRI

19
New cards

VENLAFAXINE (Effexor)

SNRI

SEs: dry mouth, insomnia, blurred vision, high BP

20
New cards

DESVENLAFAXINE (Pristiq)

SNRI

SEs: dry mouth, insomnia, blurred vision, high BP

21
New cards

DULOXETINE (Cymbalta)

SNRI

SE: seizures, dry mouth, insomnia, blurred vision, high BP

22
New cards

BUPROPRION (Wellbutrin)

NDRI

  • SEs: lowers seizure threshold (convulsions), insomnia, dry mouth, nausea

23
New cards

TRAZODONE (Desyrel)

5-HT2 Receptor Modulator: simultaneously modulate one+ R and inhibit NT reuptake

SE: dry mouth, N/V, fatigue, sedation (tx for insomnia) - all manageable

24
New cards

Chlorpromazine (Thorazine)

Classic/typical neuroleptic (first gen) antipsychotic — dopamine receptor blocker

  • SE of parkinsonism (extrapyramidal effect), hyperprolactinemia, effective against positive sx

25
New cards

Haloperidol (Haldol)

Classic/typical neuroleptic (first gen) antipsychotic — dopamine receptor blocker

  • SE of parkinsonism (extrapyramidal effect, like Tardive dyskinesia), effective against positive sx

26
New cards

ARIPIPRAZOLE (Abilify)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

27
New cards

Clozapine (Clozaril)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

  • minimal extrapyramidal SE

  • SE: seizures, agranulocytosis

28
New cards

LURASIDONE (Latuda)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

29
New cards

OLANZAPINE (Zyprexa)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

30
New cards

QUETIAPINE (Seroquel)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

31
New cards

RISPERIDONE (Risperdal)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

  • fewer

32
New cards

ZIPRASIDONE (Geodon)

Atypical (second gen) antipsychotic: better option! less SE because weaker D2 block, effective against both positive and negative

33
New cards

LITHIUM CARBONATE (Lithonate)

Treat Bipolar disorder by decreasing frequency and severity of mood fluctuations

  • Unknown mechanism of action, but …thought to help strengthen neuronal connections in brain that regulate mood, thinking, and behavior

  • Decrease NE release and increase 5-HT synthesis

  • Low therapeutic index

34
New cards

CARBAMAZEPINE (Tegretrol)

anticonvulsant to treat bipolar disorder

35
New cards

VALPROIC ACID (Valproate)

anticonvulsant to treat bipolar disorder